Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Migraine With or Without Aura in Adolescents”

7 trials

Showing 7 of 7 results

Large-scale testing (Phase 3)Looking for participantsNCT04743141
What this trial is testing

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Who this might be right for
Acute Treatment of Migraine
Pfizer 600
Large-scale testing (Phase 3)Ended earlyNCT03338920
What this trial is testing

Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents

Who this might be right for
Acute Migraine With or Without Aura
Currax Pharmaceuticals 159
Large-scale testing (Phase 3)Study completedNCT01004263
What this trial is testing

Evaluate the Safety and Tolerability of Rizatriptan for Long Term Treatment of Acute Migraine in Children and Adolescents (MK-0462-086 AM3)

Who this might be right for
Acute Migraine With or Without Aura in Adolescents
Organon and Co 674
Large-scale testing (Phase 3)Study completedNCT00843024
What this trial is testing

Migraine Study in Adolescent Patients

Who this might be right for
Migraine Disorders
GlaxoSmithKline 589
Large-scale testing (Phase 3)Looking for participantsNCT05125302
What this trial is testing

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Who this might be right for
Migraine
AbbVie 1,059
Large-scale testing (Phase 3)Enrolling By InvitationNCT05127954
What this trial is testing

Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)

Who this might be right for
Migraine
AbbVie 1,200
Large-scale testing (Phase 3)Looking for participantsNCT04649242
What this trial is testing

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Who this might be right for
Pediatric Migraine
Pfizer 2,100

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation